1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. Cytochrome P450
  4. CYP19 Isoform

CYP19

 

CYP19 Related Products (31):

Cat. No. Product Name Effect Purity
  • HY-14248
    Letrozole
    Inhibitor 99.92%
    Letrozole (CGS 20267) is a potent, selective, reversible and orally active non-steroidal inhibitor of aromatase, with an IC50 of 11.5 nM.
  • HY-13632
    Exemestane
    Inhibitor 99.92%
    Exemestane (FCE 24304) is a selective, irreversible and orally active steroidal aromatase inhibitor with IC50s of 30 nM and 40 nM for human placental and rat ovarian aromatase, respectively.
  • HY-14274
    Anastrozole
    Inhibitor 99.99%
    Anastrozole is a potent, highly selective aromatase inhibitor, which inhibits human placental aromatase with an IC50 of 15 nM.
  • HY-18719B
    Endoxifen hydrochloride
    Inhibitor 98.20%
    Endoxifen hydrochloride is a key active metabolite of Tamoxifen (TAM) with higher affinity and specificity to estrogen receptor that also inhibits aromatase activity.
  • HY-14247A
    Fadrozole
    Inhibitor 99.69%
    Fadrozole (CGS 16949A free base) is a potent, selective and nonsteroidal inhibitor of aromatase with an IC50 of 6.4 nM.
  • HY-152250
    Antibacterial agent 132
    Inhibitor
    Antibacterial agent 132 has anticandidal effects against C.
  • HY-148430
    Aromatase-IN-2
    Inhibitor
    Aromatase-IN-2 is a potent aromatase inhibitor with an IC50 value of 1.5 µM.
  • HY-125833
    Alpha-Naphthoflavone
    Inhibitor 98.35%
    Alpha-Naphthoflavone is a flavonoid, acts as a potent and competitive aromatase inhibitor with an IC50 and a Ki of 0.5 and 0.2 μM, respectively.
  • HY-N0292
    Oleuropein
    Inhibitor 99.05%
    Oleuropein, found in olive leaves and oil, exerts antioxidant, anti-inflammatory and anti-atherogenic effects through direct inhibition of PPARγ transcriptional activity.
  • HY-14247
    Fadrozole hydrochloride
    Inhibitor 99.22%
    Fadrozole hydrochloride (CGS 16949A) is a potent, selective and nonsteroidal inhibitor of aromatase with an IC50 of 6.4 nM.
  • HY-18719E
    Endoxifen
    Inhibitor
    Endoxifen is a key active metabolite of tamoxifen (TAM) with higher affinity and specificity to estrogen receptor that also inhibits aromatase activity.
  • HY-N9551
    Eriodictyol chalcone
    Inhibitor
    Eriodictyol chalcone possesses both anti-aromatase and an anti-17β-HSD activity.
  • HY-N7128
    Flavanone
    Inhibitor 99.84%
    Flavanone is a naturally occurring flavone.
  • HY-14247B
    Fadrozole hydrochloride hemihydrate
    Inhibitor
    Fadrozole hydrochloride hemihydrate is an orally active, potent, selective and nonsteroidal aromatase inhibitor, with an IC50 of 6.4 nM.
  • HY-14274S
    Anastrozole-d12
    Inhibitor
    Anastrozole-d12 (ZD1033-d12) is the deuterium labeled Anastrozole.
  • HY-18719ES
    Endoxifen-d5
    Inhibitor
    Endoxifen-d5 is the deuterium labeled Endoxifen.
  • HY-146688
    SYN20028567
    Inhibitor
    SYN20028567 is an aromatase (CYP19) inhibitor with an IC50 of 9.4 nM.
  • HY-150775
    Nonsteroidal aromatase inhibitor 1
    Inhibitor
    Nonsteroidal aromatase inhibitor 1 (Compound 13h) is a nonsteroidal aromatase (CYP19A1) inhibitor (IC50=0.09 nM).
  • HY-N8405
    Isolimonexic acid
    Inhibitor
    Isolimonexic acid is a limonoid isolated from lemon (Citrus lemon L.
  • HY-W392925
    (R)-(+)-Aminoglutethimide
    Inhibitor
    (R)-(+)-Aminoglutethimide is a potent and orally active aromatase inhibitor.